Henry Kranzler of the Perelman School of Medicine says that the three current FDA-approved drugs for alcohol use disorder are only modestly better than placebos.
President Liz Magill is announced as a new member of the Board of Directors and the Executive Committee of the Chamber of Commerce for Greater Philadelphia.
The Congressional Budget Office’s new $400 billion estimate for President Biden’s forgiveness plan is noted as slightly less than the Wharton School’s $605B assessment.
Paul Offit of the Perelman School of Medicine says that uncertain benefits for children and lack of historical data on bivalent vaccines might not justify pediatric authorizations for omicron boosters.
The Penn Wharton Budget estimates that all three components of President Biden’s forgiveness plan will cost about $600 billion over 10 years.
